Abstract

"Pill-in-Pocket" Anticoagulation for Atrial Fibrillation: Fiction, Fact, or Foolish?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Role of atrial fibrillation burden in assessing thromboembolic risk.
Jonathan W Waks ... Taya V Glotzer
Circulation. Arrhythmia and electrophysiology | VOL. 7
Jonathan W Waks, et. al.Jonathan W Waks ... Taya V Glotzer
01 Dec 2014
Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective
Mintu P Turakhia ...
Heart Rhythm | VOL. 17
Mintu P Turakhia, et. al.Mintu P Turakhia ...
05 May 2020
Barriers to Anticoagulation in Patients With Atrial Fibrillation
Gregory Y.H Lip ... Deirdre A Lane
Stroke | VOL. 39
Gregory Y.H Lip, et. al.Gregory Y.H Lip ... Deirdre A Lane
29 Nov 2007
Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation
Justin Z Lee ... Rebecca Chester
CASE | VOL. 2
Justin Z Lee, et. al.Justin Z Lee ... Rebecca Chester
07 Mar 2018
View more papers

More From: Circulation

Paper Title
Journal
Date
Author
Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
Shiro Nakamori ... Reza Nezafat
Circulation | VOL. -
Shiro Nakamori, et. al.Shiro Nakamori ... Reza Nezafat
29 May 2024
Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association.
Shahnawaz Amdani ... Daphne T Hsu
Circulation | VOL. -
Shahnawaz Amdani, et. al.Shahnawaz Amdani ... Daphne T Hsu
29 May 2024
Evolving Cardiac Safety in Drug Discovery: Time for Immunology Integration.
Jose M Vicencio ... Amy Pointon
Circulation | VOL. 149
Jose M Vicencio, et. al.Jose M Vicencio ... Amy Pointon
28 May 2024
Response by Henriksen et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial".
Peter A Henriksen ... Ninian N Lang
Circulation | VOL. 149
Peter A Henriksen, et. al.Peter A Henriksen ... Ninian N Lang
28 May 2024
View more papers